In part, this change may be caused by GP - mediated modulations of the TSST - 1 induced binding of NFkappaB, NFIL - 6 and NFAT to known and up to now unknown sites within the IL - 8 and IL - 1RA promoter instead of the TNFalpha, IL - 1beta, IL - 6 or IFNgamma promoter.	"TSST - 1	71	79	Protein"	"NFIL - 6	109	117	Protein"	"NFAT	122	126	Protein"	"IL - 8	175	181	Protein"	"IL - 1RA	186	194	Protein"	"TNFalpha	219	227	Protein"	"IL - 1beta	229	239	Protein"	"IL - 6	241	247	Protein"	"IFNgamma	251	259	Protein"	"[{""token"": ""TSST - 1"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""NFIL - 6"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""NFAT"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""IL - 1RA"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 241, ""end_span"": 247, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Protein""}]"
To determine whether the DNA binding proteins were related to NFkappaB and NFAT, dot blots using a SRC96D SNS minifold I dot blotter ( Schleicher & Schull, Dassel, Germany) were performed with the following positive controls and antibodies ( all from Santa Cruz Biotechnology, Heidelberg, Germany): positive controls ( 10 ng / dot): NFkappaB p52 ( 80 kD) sc - 4095WB, c - Rel ( 61 kD) sc - 4030WB; Jurkat nuclear extract, PMA - stimulated; primary antibodies ( 1 mug / dot): anti - NFkappaB p50 ( NLS) sc - 114, anti - NFkappaB p65 ( A) sc - 109, anti - NFkappaB p52 ( 447) sc - 848, a rabbit polyclonal IgG1 antiserum, anti - c - rel ( N466) sc - 272, anti - NFATc2 ( M - 20) sc - 1151, anti - NFATc1 ( K - 18) sc - 1149, two goat polyclonal IgG1 antisera; secondary antibodies ( 0. 8 mug / dot): goat anti - rabbit IgG AP - conjugate sc - 2007, and donkey anti - goat IgG AP - conjugate sc - 2022.	"NFAT	75	79	Protein"	"p52	342	345	Protein"	"c - Rel	368	375	Protein"	"p50	491	494	Protein"	"p65	528	531	Protein"	"p52	563	566	Protein"	"c - rel	627	634	Protein"	"NFATc2	660	666	Protein"	"NFATc1	695	701	Protein"	"[{""token"": ""NFAT"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 342, ""end_span"": 345, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 368, ""end_span"": 375, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 491, ""end_span"": 494, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 528, ""end_span"": 531, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 563, ""end_span"": 566, ""type"": ""Protein""}, {""token"": ""c - rel"", ""start_span"": 627, ""end_span"": 634, ""type"": ""Protein""}, {""token"": ""NFATc2"", ""start_span"": 660, ""end_span"": 666, ""type"": ""Protein""}, {""token"": ""NFATc1"", ""start_span"": 695, ""end_span"": 701, ""type"": ""Protein""}]"
Whereas the majority of IkappaBs ( IkappaBalpha, IkappaBbeta, IkappaBepsilon, p105 ( also known as NF - kappaB1), p100 ( also known as NF - kappaB2)) serve as inhibitors of NF - kappaB, IkappaBxi and Bcl - 3 instead potentiate NF - kappaB transactivation in the nucleus.	"IkappaBalpha	35	47	Protein"	"IkappaBbeta	49	60	Protein"	"IkappaBepsilon	62	76	Protein"	"p105	78	82	Protein"	"NF - kappaB1	99	111	Protein"	"p100	114	118	Protein"	"NF - kappaB2	135	147	Protein"	"IkappaBxi	186	195	Protein"	"Bcl - 3	200	207	Protein"	"[{""token"": ""IkappaBalpha"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""IkappaBepsilon"", ""start_span"": 62, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""NF - kappaB1"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""NF - kappaB2"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""IkappaBxi"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""Bcl - 3"", ""start_span"": 200, ""end_span"": 207, ""type"": ""Protein""}]"
For example, TLR4 stimulation by lipopolysaccharide induces the recruitment of Toll / IL - 1 receptor adaptor protein ( also referred to as Mal) and TRIF - related adaptor molecule ( TRAM), which most probably serve as bridging factors to recruit myeloid differentiation primary response gene 88 ( MyD88) and TIR domain - containing adaptor - inducing IFNbeta ( TRIF), respectively.	"TLR4	13	17	Protein"	"Toll / IL - 1 receptor adaptor protein	79	117	Protein"	"Mal	140	143	Protein"	"TRIF - related adaptor molecule	149	180	Protein"	"TRAM	183	187	Protein"	"myeloid differentiation primary response gene 88	247	295	Protein"	"MyD88	298	303	Protein"	"TIR domain - containing adaptor - inducing IFNbeta	309	359	Protein"	"TRIF	362	366	Protein"	"[{""token"": ""TLR4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""Toll / IL - 1 receptor adaptor protein"", ""start_span"": 79, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""Mal"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""TRIF - related adaptor molecule"", ""start_span"": 149, ""end_span"": 180, ""type"": ""Protein""}, {""token"": ""TRAM"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Protein""}, {""token"": ""myeloid differentiation primary response gene 88"", ""start_span"": 247, ""end_span"": 295, ""type"": ""Protein""}, {""token"": ""MyD88"", ""start_span"": 298, ""end_span"": 303, ""type"": ""Protein""}, {""token"": ""TIR domain - containing adaptor - inducing IFNbeta"", ""start_span"": 309, ""end_span"": 359, ""type"": ""Protein""}, {""token"": ""TRIF"", ""start_span"": 362, ""end_span"": 366, ""type"": ""Protein""}]"
Upon binding of their ligand, CD40 and RANK interact with several TRAF members, including TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6, and this leads to the proteolysis of both TRAF2 and TRAF3, which represents an important step in the activation of the noncanonical pathway as described above.	"CD40	30	34	Protein"	"RANK	39	43	Protein"	"TRAF1	90	95	Protein"	"TRAF2	97	102	Protein"	"TRAF3	104	109	Protein"	"TRAF5	111	116	Protein"	"TRAF6	122	127	Protein"	"TRAF2	171	176	Protein"	"TRAF3	181	186	Protein"	"[{""token"": ""CD40"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""RANK"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""TRAF1"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""TRAF3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""TRAF5"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""TRAF3"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Protein""}]"
CYLD is a deubiquitinating enzyme that negatively regulates NF - kappaB signalling initiated by TNFR, RANK and T - cell receptor stimulation ( reviewed in [ 64]) ( Figure 1), by deubiquitina - ting several NF - kappaB signalling proteins including NEMO, TRAF2, TRAF6, TRAF7, RIP1 and TAK1.	"CYLD	0	4	Protein"	"deubiquitinating enzyme	10	33	Protein"	"RANK	102	106	Protein"	"NEMO	248	252	Protein"	"TRAF2	254	259	Protein"	"TRAF6	261	266	Protein"	"TRAF7	268	273	Protein"	"RIP1	275	279	Protein"	"TAK1	284	288	Protein"	"[{""token"": ""CYLD"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""deubiquitinating enzyme"", ""start_span"": 10, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""RANK"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""NEMO"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 261, ""end_span"": 266, ""type"": ""Protein""}, {""token"": ""TRAF7"", ""start_span"": 268, ""end_span"": 273, ""type"": ""Protein""}, {""token"": ""RIP1"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Protein""}, {""token"": ""TAK1"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Protein""}]"
Although CD86 gene expression did not depend on MyD88 ( Figure 7B), abrogation of IRAK1 and TRAF6 gene expression significantly reduced CD86 mRNA levels, indicating that CD86 expression is IRAK1 - and TRAF6 - dependent, but MyD88 - independent in MTb - infected monocytes ( Figures 7C - 7D).	"CD86	9	13	Protein"	"MyD88	48	53	Protein"	"IRAK1	82	87	Protein"	"TRAF6	92	97	Protein"	"CD86	136	140	Protein"	"CD86	170	174	Protein"	"IRAK1	189	194	Protein"	"TRAF6	201	206	Protein"	"MyD88	224	229	Protein"	"[{""token"": ""CD86"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""MyD88"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""IRAK1"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""CD86"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Protein""}, {""token"": ""CD86"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Protein""}, {""token"": ""IRAK1"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""MyD88"", ""start_span"": 224, ""end_span"": 229, ""type"": ""Protein""}]"
